Heparin coating of human breast carcinoma cells in vivo

  • Authors:
    • F Hartveit
  • View Affiliations

  • Published online on: May 1, 1997     https://doi.org/10.3892/or.4.3.497
  • Pages: 497-499
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Mast cells, the only source of heparin in the body, are common in breast carcinoma. Due to metachromatic staining of heparin-proteoglycans released from the mast cells toluidine blue may stain connective tissue a reddish-purple. This study shows that tumour cells in the vicinity may also be coated with metachromatic substance. Such bl vivo coating does not appear to have been reported previously. In experimental studies in vitro coating has been described following suspension of mouse tumour cells in a heparin solution and preincubation of ascitic tumour cells in heparin has given reduction in survival time after transplantation. In human breast carcinoma stromal metachromasia may under certain circumstances be indicative of poor prognosis. The biological implications of in vivo tumour cell coating with heparin are under investigation.

Related Articles

Journal Cover

May 1997
Volume 4 Issue 3

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Hartveit F: Heparin coating of human breast carcinoma cells in vivo. Oncol Rep 4: 497-499, 1997.
APA
Hartveit, F. (1997). Heparin coating of human breast carcinoma cells in vivo. Oncology Reports, 4, 497-499. https://doi.org/10.3892/or.4.3.497
MLA
Hartveit, F."Heparin coating of human breast carcinoma cells in vivo". Oncology Reports 4.3 (1997): 497-499.
Chicago
Hartveit, F."Heparin coating of human breast carcinoma cells in vivo". Oncology Reports 4, no. 3 (1997): 497-499. https://doi.org/10.3892/or.4.3.497